ZYMAGENX Trademark

Trademark Overview

On Monday, May 12, 2025, a trademark application was filed for ZYMAGENX with the United States Patent and Trademark Office. The USPTO has given the ZYMAGENX trademark a serial number of 99179766. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 12, 2025. This trademark is owned by ZymagenX, Inc.. The ZYMAGENX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of celiac disease; Pharmaceutical products for the treatment of autoimmune diseases, namely, celiac disease; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes

Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
zymagenx

General Information

Serial Number99179766
Word MarkZYMAGENX
Filing DateMonday, May 12, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, May 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of celiac disease; Pharmaceutical products for the treatment of autoimmune diseases, namely, celiac disease; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes
Goods and ServicesPharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZymagenX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Monday, May 12, 2025NEW APPLICATION ENTERED
Monday, May 12, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

zymagenx pharmaceutical diseases disorders treatment preparations research autoimmune clinical field scientific